Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease
Simvastatin as a Neuroprotective Treatment for Parkinson's Disease: a Double-blind, Randomised, Placebo Controlled Futility Study in Patients of Moderate Severity. Simvastatinas a Neuroprotective Treatment for Parkinson's Disease: a Double-blind, Randomised, Place ...
A trial comparing simvastatin to placebo as a neuronal protective treatment for Parkinson's disease.
Simvastatin as a neuroprotective treatment for Parkinson's disease: a double-blind, randomised, placebo controlled futility study in patients of moderate severity. - Simvastatin as a neuroprotective treatment for moderate PD (PD STAT) Simvastatinas a neuroprotective treatment for Parkinson's disease: a double-blind, randomised, place ...
Parkinson's disease MedDRA version: 18.0;Level: PT;Classification code 10061536;Term: Parkinson's disease;System Organ Class: 10029205 - Nervous system disorders MedDRA version: 18.0;Level: LLT;Classification code 10013113;Term: Disease Parkinson's;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] Parkinson's disease MedDRA version: 18.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...
Etude pilote de phase II, N=1 en crossover répétés, en double aveugle, randomiséeversus placebo, multicentrique, évaluant l’efficacité de la SIMVAstatine sur lesDYSkinésies induites par la L-Dopa chez des patients atteints de maladie de Parkinson - SIMVADYS Etude pilote de phase II, N=1 en crossover répétés, en double aveugle, randomiséeversus placebo, mul ...
Etude pilote de phase II, N=1 en crossover répétés, en double aveugle, randomiséeversus placebo, multicentrique, évaluant l’efficacité de la SIMVAstatine sur lesDYSkinésies induites par la L-Dopa chez des patients atteints de maladie de Parkinson - SIMVADYS Etude pilote de phase II, N=1 en crossover répétés, en double aveugle, randomiséeversus placebo, mul ...